Docking scores do not establish binding affinity or therapeutic efficacy: concerns regarding the interpretation of in silico findings on TTK inhibition in lung adenocarcinoma
This Matters Arising commentary addresses the recent article by Patidar et al. ( 2026 ) on TTK-mediated ceRNA networks in lung adenocarcinoma. We identify two critical scientific issues that are not addressed in the original paper’s Limitations section. First, the authors interpret molecular docking scores as evidence of binding affinity and inhibitory activity, which is scientifically unsupported. Second, the therapeutic recommendation for hesperidin lacks any functional validation, as no enzymatic, cellular, or in vivo assays were performed. These concerns fundamentally affect the validity of the paper’s therapeutic conclusions and warrant clarification.
Authors
- Ehsan Khodamoradi (ORCID: https://orcid.org/0000-0002-9053-3155)
Institutions
- Kermanshah University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1007/s00432-026-06657-9
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00